Impact of 1-month Dual Antiplatelet Therapy After Treatment with Drug-Coated Balloon for Femoropopliteal Artery Disease

Impact of 1-month Dual Antiplatelet Therapy After Treatment with Drug-Coated Balloon for Femoropopliteal Artery Disease - 1-month DAPT After Treatment with DCB for Femoropopliteal Artery Lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034867

Enrollment

150

Registered

2018-11-12

Start date

2018-10-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis obliterans

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with femoropopliteal artery disease which are suitable to be received DCB therapy

Exclusion criteria

Exclusion criteria: Patients who are needed to receive long-term DAPT Patients who are treated with anticoagulant agent Patients without tolerance to aspirin or clopidogrel

Design outcomes

Primary

Measure	Time frame
The primary petency at 12 months	—

Secondary

Measure	Time frame
The incidence of thrombosis at 12 months	—

Countries

Japan

Contacts

Public ContactMiki Kojiro

Hyogo College of Medicine Division of Cardiovascular Medicine and Coronary Heart Disease

hpxkg043@ybb.ne.jp0798-45-6553

Outcome results